loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2011_390___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Kyongbo Pharmaceutical Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR (1)

    filter

    01 Ceftazidime Pentahydrate, Sterile (1)

    filter

    01 South Korea (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    KYONGBO PHARMACEUTICAL CO., LTD. As...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ceftazidime Pentahydrate, Sterile

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2011-390 - Rev 00
    Withdrawn by Holder
    Chemical
    2018-11-21
    2021-07-27
    1405
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-390 - Rev 00 of Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-390 - Rev 00 of Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr 1

    20

    Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Ceftazidime Pentahydrate, Sterile, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-390 - Rev 00

    This Chemical Type CEP, issued on November 21, 2018, remains in force until July 27, 2021, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1405 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY